Frank Haluska, SVP, Clinical R&D, CMO at ARIAD PHARMACEUTICALS INC (ARIA), sold 21,176 shares at $6.11 ($129K) on 2016-03-03, disclosed to the SEC on 2016-03-03.
Seasonal sale ($129k) by SVP, Clinical R&D, CMO — this insider has traded ARIA in March in at least three consecutive prior years. Pattern-driven, low signal.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $6.11 | 10,588 | $65K | 50.0% |
| 2 | $6.11 | 10,588 | $65K | 50.0% |
| Total | $6.11 avg | 21,176 | $129K | 100% |
| Filing → |
| ARIA | SELL | 2015-09-28 | $36K | — | Filing → |
| ARIA | SELL | 2015-07-16 | $38K | — | Filing → |
| ARIA | SELL | 2015-03-23 | $60K | — | Filing → |